Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-23
2011-08-23
Hui, San-Ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
08003688
ABSTRACT:
The present invention relates to methods of treating conditions and/or symptoms related to common cold of the upper and/or lower respiratory tract and/or eyes. In particular the invention relates to the methods of treating conditions and/or symptoms related to common cold comprising administration of a flavonoid or administration of a flavonoid in combination with a metal. The invention furthermore describes compositions comprising a metal and a flavonoid useful for the treatment of conditions and/or symptoms relates to common cold.
REFERENCES:
patent: 3420815 (1969-01-01), Courbat
patent: 3516984 (1970-06-01), Courbat
patent: 4888326 (1989-12-01), Horrobin
patent: 4956385 (1990-09-01), Eby, III
patent: 5096887 (1992-03-01), Casley-Smith
patent: 5834000 (1998-11-01), Yng-Wong
patent: 5888527 (1999-03-01), Nashimoto et al.
patent: 5922756 (1999-07-01), Chan
patent: 5935996 (1999-08-01), Yamaguchi
patent: 6224872 (2001-05-01), Shibuya et al.
patent: 3603227 (1987-08-01), None
patent: 19949575 (2001-04-01), None
patent: 0204987 (1986-12-01), None
patent: 0396251 (1990-11-01), None
patent: 0417385 (1991-03-01), None
patent: 0754450 (1997-01-01), None
patent: 0861662 (1998-09-01), None
patent: 04368331 (1992-12-01), None
patent: 08239319 (1996-09-01), None
patent: 09056333 (1997-03-01), None
patent: 09227373 (1997-09-01), None
patent: 10257856 (1998-09-01), None
patent: 11100325 (1999-04-01), None
patent: 10110785 (1999-11-01), None
patent: 11302184 (1999-11-01), None
patent: 2000327573 (2000-11-01), None
patent: WO 88/03800 (1988-06-01), None
patent: WO 88/03805 (1988-06-01), None
patent: WO 97/27177 (1997-07-01), None
patent: WO 98/30228 (1998-07-01), None
patent: WO 98/47534 (1998-10-01), None
patent: WO 99/07381 (1999-02-01), None
patent: WO99/16319 (1999-04-01), None
patent: WO 00/70949 (2000-11-01), None
patent: WO 01/03681 (2001-01-01), None
patent: WO 01/49285 (2001-07-01), None
patent: 02076422 (2002-10-01), None
van Acker et al., Cancer Research, 1993;53(19):4603-4607 (abstract.
Powell, Journal of Nutrition, 2000;130(5):1447S-1454S.
Kang, Experimental Biology and Medicine, 1999;222(3):263-273.
Baumann, et al., “Flavonoids and Related. Compounds as Inhibitors of Arachidonic Acid Peroxidation”,Prostaglandins,Jul. 1980.
“The Merck Manual of Diagnosis and Therapy”, Merck Research Laboratories, Seventeenth Edition, Whitehouse Station, N.J., pp. 556-569, chapter 68, section 6, 1999.
M. H. Beers, M. d. berkow, The Merch manual of diagnosis and therapy, p. 1277-1293, 1999 Merck Research.
J. V. Formica, W. Regelson, Review of the biology of quercetin and related bioflavonoids., Fd Chem. Toxic. vol. 33, No. 12, pp. 1061-1080, 1995.
J. E. F. Reynolds, Martindale—The extra phamacopoeia, thirty-first edition, pp. 1679-1680, 1996.
K. Parfitt, Matindale—The complete drug reference . . . pp. 1373-1374.
Tej N. Kaul, Elliot Middleton Jr., Pearay L. Ogra., Antiviral effect of flavonoids on human viruses, Journal of Medical Virology 15:71-79, 1985.
S. B. Mossad, M. L. Macknin, S. V. Medendorph, P. Mason, Zinc gluconate lozenges for treating the common cold, Annals of internal medicine vol. 125, p. 81-88, 1996.
I.M. Selivanova, N.A. Tyukavkina, Yu.A. Kolesnik, V.K. Kolkhir, V.Lyubimov, Investigation of absorption of diquertin in vitro gastrointestinal model, Farmatsiya, 47:27-28, 1998.
M. Tordea, M. L. Ferrándiz, M. J. Alcaraz, Influence of anti-inflammatory flavonoids on degranulation and arachidonic acid release in rat neutrophils, Z. Naturforsch, vol. 49, p. 235-240, 1993.
Abisheganaden, et al., “Effect of Clarithromycin on Experimental Rhinovirus-16 Colds: A Randomized, Double-Blind, Controlled Trial”,The American Journal of Medicine,vol. 108, pp. 453-459, Apr. 15, 2000.
Berg, et al., “Zinc Potentiates the Antiviral Action of Human IFN-α Tenfold”,Journal of Interferon and Cytokine Research,vol. 21, pp. 471-474, 2001.
Black, P.N., “Anti-inflammatory effects of macrolide antibiotics”,Eur. Respir J.,vol. 10, pp. 971-972, 1997.
Bardsley-Elliot, et al., “Oseltamivir”,Drugs,vol. 58(5), pp. 851-860, Nov. 1999.
Farr, et al., “A Randomized Controlled Trial of Glucoccorticoid Prophylaxis against Experimental Rhinovirus Infection”,J. Infect. Dis.,vol. 162, pp. 1173-1177, Nov. 1990.
Geist, et al., “In Vitro Activity of Zinc Salts against Human Rhinoviruses”,Antimicrobial Agents and Chemotherapy,vol. 31, No. 4, pp. 622-624, Apr. 1987.
Jackson, et al., “Zinc and the Common Cold: A Meta-Analysis Revisted”,J. Nutr.,vol. 130, pp. 1512s-1515s, 2000.
Lorber, Bennett MD, “The Common Cold”Journal of General Internal Medicine,vol. 11, pp. 229-236, Apr. 1996.
Rink, et al., “Zinc-Altered Immune Function and Cytokine Production”,J. Nutr.,vol. 130, pp. 1407S-1411S, 2000.
Cooper Iver P.
Hui San-ming
ImmuPharm Aps
LandOfFree
Method of treating symptoms of common cold, allergic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating symptoms of common cold, allergic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating symptoms of common cold, allergic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2767173